Zydus Lifesciences Limited

NSE:ZYDUSLIFE.NS

1054.45 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003
Operating Activities:
Net Income 48,38125,82752,32322,84814,95423,82123,12016,11921,23714,4559,4228,0877,9428,4256,0393,0312,5762,3381,5241,2151,331
Depreciation & Amortization 7,6417,2277,3617,2486,9655,9865,4053,7503,0222,8732,0121,8471,5791,2691,3391,118969823779716712
Deferred Income Tax 000000000000000000000
Stock Based Compensation 000000000000000000000
Change In Working Capital -8,711-2,358-3,5151,8681,2946,378-13,839-3,7282,656-3,770-359-1,996-4,452-2,054-1,236-1,210-2,115-628-1,34516482
Accounts Receivables -7,472-8,485-1,8174,3135,636-6,428-9,690-5,051-1,110-4,506-1,762-740000000000
Inventory -204,407-5,255-4,797-1,010-1,004-5,924-4,666845-1,682-1,540-1,230-2,786-615-1,492-1,283-833-1,421-254-453245
Accounts Payables -448-1,708-1,2031,709564-2,2593,1642,3372,578000000000000
Other Working Capital -7713,4284,760643-3,89616,069-7,9159381,811-2,0881,181-766-1,666-1,43925673-1,282793-1,091617-163
Other Non Cash Items -370-3,808-35,1289661,841-7,362-5,493-2,646-6,977-3,622-2,205-2,029-50-944182-753423-12153196214
Operating Cash Flow 32,27926,88821,04132,93025,05428,8239,19313,49519,9389,9368,8705,9095,0196,6966,3242,1861,8532,5211,1112,2912,339
Investing Activities:
Investments In Property Plant And Equipment -9,066-10,309-12,026-8,540-9,041-10,574-10,493-29,781-9,718-5,124-4,682-7,243-12,444-4,894-3,321-4,069-5,035-2,355-1,223-1,248-1,040
Acquisitions Net -7,2011,1462,0711,0351,565-48,6771404754000002801960001470
Purchases Of Investments -4,645-2,606-7,837-400-1,850-48,81300-1-115-10-903-1,665-5-842-500-247-5-556
Sales Maturities Of Investments 4,62723,3567511012851,3541165315650231,69003001072010330
Other Investing Activites 912528,585579-1,08249,323640625680587470528516369-232-227110480691422
Investing Cash Flow -14,75211,71211,544-7,225-10,123-57,387-9,737-29,103-9,039-4,647-4,222-7,595-11,903-4,530-3,815-4,095-4,918-1,674-1,401-1,072-1,174
Financing Activities:
Debt Repayment -3,929-9,960-14,208-25,683-7,855-1,704-2,646-6,447-4,684-8,998-4,209-2,941-2,902-601-1,7680000-543-526
Common Stock Issued 018,59209,86600000000000000000
Common Stock Repurchased -7,250-8,6320-8,33700000000000000000
Dividends Paid -6,210-2,671-3,722-15-8,569-3,583-10-3,271-5,789-1,839-1,533-1,523-1,266-1,012-154-709-841-398-481-506-310
Other Financing Activities -3,831-41,3339,247-1,3204,07924,1333,16132,8769467,3264557,32212,766-108-5974,2053,84210359700
Financing Cash Flow -18,104-44,004-8,683-25,489-10,94218,84651523,158-9,527-3,511-5,2872,8588,598-1,721-2,5193,4963,001-295116-1,049-836
Other Information:
Effect Of Forex Changes On Cash -2316686-42791,60906390000004000010
Net Change In Cash -748-5,33823,729-9053,989-7,105-297,5561,3721,778-6391,1721,714445-101,591-64552-174170339
Cash At End Of Period 4,1305,73134,60110,87211,7778,79215,89715,9269,2767,9046,1265,8384,6662,9522,5072,517926990438612442